Zobrazeno 1 - 10
of 57
pro vyhledávání: '"J J, Schrogie"'
Publikováno v:
Clinical pharmacology and therapeutics. 88(4)
To the Editor: The April 2010 issue of Clinical Pharmacology & Therapeutics focuses on the role of inflammation in the pathogenesis of cancer, obesity, and cardiovascular disease. However, another important disease with an inflammatory component, Alz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df361429fc5b4cbf2a75991dadfe08f
https://pubmed.ncbi.nlm.nih.gov/20703223
https://pubmed.ncbi.nlm.nih.gov/20703223
Autor:
J J, Schrogie
Publikováno v:
American heart journal. 137(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8fb7d4c183b1f82935933dbae392481
https://pubmed.ncbi.nlm.nih.gov/10220614
https://pubmed.ncbi.nlm.nih.gov/10220614
Publikováno v:
Best practices and benchmarking in healthcare : a practical journal for clinical and management application. 2(6)
Technology assessment has become a rapidly growing component of the healthcare system. It has assumed a functional role in operational settings and is rapidly impacting decisions involving purchasing, coverage, and reimbursement. This review is inten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a1a22971eb55f0fcff07014d301821c
https://pubmed.ncbi.nlm.nih.gov/9543920
https://pubmed.ncbi.nlm.nih.gov/9543920
Autor:
J M Mullin, J J Schrogie
Publikováno v:
Clinical Pharmacology & Therapeutics. 93:150-150
government-funded large-scale epigenome projects in several countries that are cataloging epigenetic patterns across the genome in human tissues in normal and disease states.4 These projects have started yielding data that have now been published and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd1b826b18cad096e8a640089e2d531
https://doi.org/10.1038/clpt.2012.182
https://doi.org/10.1038/clpt.2012.182
Autor:
J J, Schrogie, D B, Nash
Publikováno v:
Topics in hospital pharmacy management. 13(4)
Pharmacy and therapeutics committees can use pharmacoeconomic and outcome studies as tools to evaluate and implement clinical guidelines for patient care. Results of studies help optimize the clinical effects and control the costs of drug therapy. Su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a9e2076ec8c8bc7726a20f3f367fc1af
https://pubmed.ncbi.nlm.nih.gov/10130682
https://pubmed.ncbi.nlm.nih.gov/10130682
Publikováno v:
Antimicrobial Agents and Chemotherapy. 17:847-855
To characterize the effect of orally administered probenecid on the pharmacokinetics of cefoxitin in healthy male volunteers, we administered to one group of six subjects 2 g of cefoxitin by intravenous (i.v.) bolus either alone, with 1 g of probenec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aaf9ec70730d220f3a971ddb64f96c7
https://doi.org/10.1128/aac.17.5.847
https://doi.org/10.1128/aac.17.5.847
Autor:
J. J. Schrogie
Publikováno v:
The Focus for Pharmaceutical Knowledge ISBN: 9781349095735
I would like to begin by giving a general definition of ‘phase IV studies’ for the purposes of this discussion. Such studies are large scale, population-based evaluations of drugs after marketing approval has been obtained. The study protocols ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd91b5dc262a69758363f4a1c1e2553f
https://doi.org/10.1007/978-1-349-09571-1_18
https://doi.org/10.1007/978-1-349-09571-1_18
Autor:
J. D. Rogers, G. I. Holmes, J. J. Schrogie, H. Skeggs, K. C. Yeh, C. M. Martin, Richard O. Davies
Publikováno v:
Reviews of infectious diseases. 1(1)
Features of the distribution, metabolism, elimination, and pharmacokinetics of the cephalosporins and cefoxitin must be considered when concentrations of these drugs in biological fluids are interpreted. The extensive (--86%) binding of cefazolin to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633e78827e9df3993aaf3d5df0c45b28
https://pubmed.ncbi.nlm.nih.gov/318227
https://pubmed.ncbi.nlm.nih.gov/318227
Publikováno v:
Clinical therapeutics. 8(1)
A postmarketing surveillance study was conducted to determine the safety and efficacy of a fixed-ratio combination containing 10 mg of timolol maleate and 25 mg of hydrochlorothiazide, administered twice daily for one month to hypertensive patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da691c02ce4cac091b6f328807aa04d0
https://pubmed.ncbi.nlm.nih.gov/3833372
https://pubmed.ncbi.nlm.nih.gov/3833372
Autor:
C. M. Martin, D. Rogers, J. J. Schrogie, K. C. Yeh, H. Skeggs, Richard O. Davies, G. I. Holmes
Publikováno v:
The Journal of antimicrobial chemotherapy. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3cef9e46ce892d3179bc300475bee69
https://pubmed.ncbi.nlm.nih.gov/99418
https://pubmed.ncbi.nlm.nih.gov/99418